Skip to main content

Table 3 Number of BOABS Study participants who had stopped smoking at final follow-up

From: The Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote aboriginal Australian health care setting

Outcome

Usual care group

Intervention group

P*

RR (95% CI)†

Urinary cotinine <50 ng/mL

5/64 (8%)

8/28 (29%)

0.009

3.7 (1.3–10.2)

Self-report quitting and urinary cotinine <50 ng/mL for participants with complete outcome data

5/95 (5%)

6/49 (12%)

0.135

2.3 (0.7–7.2)

Self-report quitting and urinary cotinine <50 ng/mL assuming those lost to follow-up were still smoking

5/108 (5%)

6/55 (11%)

0.131

2.4 (0.8–7.4)

  1. Data are number (%) based on the study arm to which participants were originally assigned;
  2. *Fishers exact;
  3. †Compared with usual care group;
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us